palmitic acid has been researched along with Cirrhosis in 10 studies
Palmitic Acid: A common saturated fatty acid found in fats and waxes including olive oil, palm oil, and body lipids.
hexadecanoic acid : A straight-chain, sixteen-carbon, saturated long-chain fatty acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In primary hepatocytes and AML-12 cells, JM-2 treatment significantly suppressed palmitic acid (PA)-induced JNK activation and PA-induced inflammation and cell apoptosis." | 4.31 | A small-molecule JNK inhibitor JM-2 attenuates high-fat diet-induced non-alcoholic fatty liver disease in mice. ( Jin, L; Liang, G; Lou, S; Luo, W; Wang, M; Yang, B; Ye, L; Zhang, Q; Zhang, Y; Zhu, W, 2023) |
| " To simulate a similar in-vivo condition, we persuaded insulin resistance in H9c2 cells by palmitic acid (PA) treatment." | 4.12 | Empagliflozin prohibits high-fructose diet-induced cardiac dysfunction in rats via attenuation of mitochondria-driven oxidative stress. ( Alam, MJ; Arava, S; Banerjee, SK; Bugga, P; Katare, P; Maulik, SK; Meghwani, H; Mohammed, SA, 2022) |
| " Here, we report that KIM-1 mediates PT uptake of palmitic acid (PA)-bound albumin, leading to enhanced tubule injury with DNA damage, PT cell-cycle arrest, interstitial inflammation and fibrosis, and secondary glomerulosclerosis." | 4.02 | KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease. ( Ajay, AK; Bonventre, JV; Brooks, CR; Chang, JH; Galichon, P; Hawkins, J; Henderson, JM; Ichimura, T; Kishi, S; Kuchroo, VK; Li, J; Li, L; Mori, Y; Mou, S; Palmer, SC; Sabbisetti, VS; Woo, HM; Xiao, S; Zhao, H, 2021) |
| " We observed that palmitic acid treatment in cardiac-derived H9c2 cells induced a significant increase in reactive oxygen species, inflammation, apoptosis, fibrosis and hypertrophy." | 3.83 | Inhibition of inflammation and oxidative stress by an imidazopyridine derivative X22 prevents heart injury from obesity. ( Chen, G; Chen, X; Li, X; Liang, G; Lu, K; Peng, K; Qian, Y; Xu, Z; Zhang, Y; Zhong, P, 2016) |
| "Renal fibrosis is a potent predictor of progression in patients and is often accompanied by inflammation and oxidative stress; however, the mechanisms involved in these alterations are not well established." | 1.62 | Role of endoplasmic reticulum stress in renal damage after myocardial infarction. ( Cachofeiro, V; de la Fuente-Chávez, L; Delgado-Valero, B; Islas, F; Luaces, M; Martínez-Martínez, E; Ramchandani, B; Romero-Miranda, A; Visitación Bartolomé, M, 2021) |
| "Treatment with Senicapoc decreased palmitic acid-driven HepG2 cell death." | 1.46 | Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease. ( Duan, B; Goldberg, ID; Hao, YJ; Jiang, K; Jung, D; Li, JS; McCormack, S; Narayan, P; Paka, L; Shi, J; Smith, DE; Yamin, M; Zhou, P, 2017) |
| "As obesity is one of the major risk factors of chronic and end-stage renal disease, we studied the role of Smad3 signaling in the pathogenesis of obesity-related renal disease." | 1.42 | Smad3 deficiency protects mice from obesity-induced podocyte injury that precedes insulin resistance. ( Bertram, JF; Caruana, G; Dai, L; Fu, P; Howard, V; Jiang, X; Li, J; Nikolic-Paterson, DJ; Puelles, VG; Qu, X; Ren, Y; Sleeman, MW; Sun, YB, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 5 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bugga, P | 1 |
| Mohammed, SA | 1 |
| Alam, MJ | 1 |
| Katare, P | 1 |
| Meghwani, H | 1 |
| Maulik, SK | 1 |
| Arava, S | 1 |
| Banerjee, SK | 1 |
| Jin, L | 1 |
| Wang, M | 1 |
| Yang, B | 1 |
| Ye, L | 1 |
| Zhu, W | 1 |
| Zhang, Q | 1 |
| Lou, S | 1 |
| Zhang, Y | 2 |
| Luo, W | 1 |
| Liang, G | 2 |
| Gao, LP | 1 |
| Chen, HC | 1 |
| Ma, ZL | 1 |
| Chen, AD | 1 |
| Du, HL | 1 |
| Yin, J | 1 |
| Jing, YH | 1 |
| Delgado-Valero, B | 1 |
| de la Fuente-Chávez, L | 1 |
| Romero-Miranda, A | 1 |
| Visitación Bartolomé, M | 1 |
| Ramchandani, B | 1 |
| Islas, F | 1 |
| Luaces, M | 1 |
| Cachofeiro, V | 1 |
| Martínez-Martínez, E | 1 |
| Mori, Y | 1 |
| Ajay, AK | 1 |
| Chang, JH | 1 |
| Mou, S | 1 |
| Zhao, H | 1 |
| Kishi, S | 1 |
| Li, J | 2 |
| Brooks, CR | 1 |
| Xiao, S | 1 |
| Woo, HM | 1 |
| Sabbisetti, VS | 1 |
| Palmer, SC | 1 |
| Galichon, P | 1 |
| Li, L | 1 |
| Henderson, JM | 1 |
| Kuchroo, VK | 1 |
| Hawkins, J | 1 |
| Ichimura, T | 1 |
| Bonventre, JV | 1 |
| Paka, L | 1 |
| Smith, DE | 1 |
| Jung, D | 1 |
| McCormack, S | 1 |
| Zhou, P | 1 |
| Duan, B | 1 |
| Li, JS | 1 |
| Shi, J | 1 |
| Hao, YJ | 1 |
| Jiang, K | 1 |
| Yamin, M | 1 |
| Goldberg, ID | 1 |
| Narayan, P | 1 |
| Khan, S | 1 |
| Cabral, PD | 1 |
| Schilling, WP | 1 |
| Schmidt, ZW | 1 |
| Uddin, AN | 1 |
| Gingras, A | 1 |
| Madhavan, SM | 1 |
| Garvin, JL | 1 |
| Schelling, JR | 1 |
| Sun, YB | 1 |
| Qu, X | 1 |
| Howard, V | 1 |
| Dai, L | 1 |
| Jiang, X | 1 |
| Ren, Y | 1 |
| Fu, P | 1 |
| Puelles, VG | 1 |
| Nikolic-Paterson, DJ | 1 |
| Caruana, G | 1 |
| Bertram, JF | 1 |
| Sleeman, MW | 1 |
| Qian, Y | 1 |
| Zhong, P | 1 |
| Peng, K | 1 |
| Xu, Z | 1 |
| Chen, X | 1 |
| Lu, K | 1 |
| Chen, G | 1 |
| Li, X | 1 |
| Lee, L | 1 |
| Ito, T | 1 |
| Nakamura, T | 1 |
| Jensen, RT | 1 |
| Igarashi, H | 1 |
| Takayanagi, R | 1 |
10 other studies available for palmitic acid and Cirrhosis
| Article | Year |
|---|---|
Empagliflozin prohibits high-fructose diet-induced cardiac dysfunction in rats via attenuation of mitochondria-driven oxidative stress.
Topics: Animals; Benzhydryl Compounds; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mel | 2022 |
A small-molecule JNK inhibitor JM-2 attenuates high-fat diet-induced non-alcoholic fatty liver disease in mice.
Topics: Animals; Diet, High-Fat; Fibrosis; Hepatocytes; Inflammation; Liver; Mice; Mice, Inbred C57BL; Non-a | 2023 |
Fibrillation of human islet amyloid polypeptide and its toxicity to pancreatic β-cells under lipid environment.
Topics: Amyloid; Apoptosis; Cell Membrane; Endoplasmic Reticulum Stress; Fatty Acids, Nonesterified; Fibrosi | 2020 |
Role of endoplasmic reticulum stress in renal damage after myocardial infarction.
Topics: Adult; Animals; Cells, Cultured; Disease Models, Animal; Endoplasmic Reticulum Stress; Female; Fibro | 2021 |
KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease.
Topics: Animals; Benzamides; Cell Cycle Checkpoints; Diabetes Mellitus, Experimental; Diabetic Nephropathies | 2021 |
Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease.
Topics: Acetamides; Animals; Apoptosis; Biomarkers, Tumor; Diet, High-Fat; Fibrosis; Gene Expression Regulat | 2017 |
Kidney Proximal Tubule Lipoapoptosis Is Regulated by Fatty Acid Transporter-2 (FATP2).
Topics: Animals; Apoptosis; Atrophy; Biological Transport; Cells, Cultured; Coenzyme A Ligases; Epithelial C | 2018 |
Smad3 deficiency protects mice from obesity-induced podocyte injury that precedes insulin resistance.
Topics: Animals; Cells, Cultured; Dietary Fats; Enzyme Inhibitors; Fibrosis; Flavonoids; Gene Knockdown Tech | 2015 |
Inhibition of inflammation and oxidative stress by an imidazopyridine derivative X22 prevents heart injury from obesity.
Topics: Animals; Apoptosis; Blood Glucose; Cardiomegaly; Cell Line; Diet, High-Fat; Fibrosis; Heart Injuries | 2016 |
Antifibrotic Effect of Saturated Fatty Acids via Endoplasmic Reticulum Stress Response in Rat Pancreatic Stellate Cells.
Topics: Actins; Animals; Apoptosis; Cells, Cultured; Diet, High-Fat; Endoplasmic Reticulum Stress; Enzyme In | 2017 |